A New Approach to Understanding Plasmin Generation and Fibrinolysis – RPTH Journal
RPTH Journal shared on LinkedIn about a recent article by Ying Dai et al, adding:
”Measuring plasmin generation: a smarter tool for studying fibrinolysis
Fibrinolysis is tightly regulated by plasmin.
Yet reliably measuring plasmin generation in preclinical and clinical settings has remained challenging.
A new study in RPTH Journal presents a novel fluorescence-based plasmin sensor (FPS) designed to address this gap.
Key findings:
- FPS showed higher efficiency for plasmin than existing peptide-based sensors
- Unlike peptide sensors, FPS is not cleaved by plasmin inhibited by α2-macroglobulin giving a more accurate readout
- FPS interacts with kringle domain 5 of plasmin, revealing novel molecular interactions
- When combined with an anti-α2-antiplasmin blocking antibody, FPS can detect nanomolar levels of plasmin
- FPS does not inhibit clot lysis, a key advantage over peptide sensors
- Plasmin generation measured with FPS showed only 2-fold variation across healthy volunteers — suggesting good reproducibility
- The sensor can also detect the influence of PAI-1 when antiplasmin is inhibited
Better tools to measure plasmin generation could significantly advance our understanding of fibrinolytic disorders and ultimately improve how we diagnose and manage conditions like hyperfibrinolysis or thrombosis.”
Title: A novel biosensor for measuring plasmin activity
Authors: Ying Dai, Paul Y. Kim, Stefan Heitmeier, Jeffrey I. Weitz, Peter L. Gross
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 20, 2026, 06:45Grant Garcia: Why Does a Blood Clot Diagnosis Immediately End an Athlete’s Season?
-
Oct 20, 2026, 06:35Parag Tamhankar: Landmark Study Reveals Genetic Spectrum and Targeted Therapies for ALPS in the Indian Population
-
Oct 20, 2026, 06:26Nina Houben: Neonatal Blood Transfusion Symposium and PhD Defense
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question